Carlo Bertozzi on building a mission-driven biotech company

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/95/bb/c0/95bbc02c-fcc9-6165-f53b-8357aa7b6f4e/mza_3772196312056908933.jpg/600x600bb.jpg

founders in biotech

Founders in biotech

14 episodes

2 days ago

Sharing the founder’s journey and scientific achievements to inspire the leaders of tomorrow. On each episode, the host Serghei Glinca, biotech entrepreneur and ecosystem builder, meets unconventional founders to talk about science, entrepreneurship, fundraising, and leadership. The shared lessons of the founder’s journey show a clear path how to take action and activate talents to start their own journey as founders. Serghei and guests also discuss practical perspectives and tools to motivate the scientific community to turn science into tangible impact.

Business

RSS

All content for founders in biotech is the property of Founders in biotech and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/24063192/24063192-1655724127724-53e4688f7a878.jpg

Carlo Bertozzi on building a mission-driven biotech company

founders in biotech

31 minutes 23 seconds

3 years ago

Carlo Bertozzi on building a mission-driven biotech company

Carlo started his biotech journey as a founder and G7 Therapeutics as a spin-off from the University of Zurich. The company developed a technology for stabilization of G protein-coupled receptors (GPCRs), a superfamily of receptors linked to a wide range of human diseases. G7 therapeutics was acquired by Sosei Heptares in 2016. But Carlo didn’t rest. He co-founded Acthera Therapeutics in 2019 and is active as a mentor. He also co-founded inCephalo, where he is currently active as CEO. With inCephalo the team is driven to change the landscape of therapeutic options for brain tumours.